Peak drug levels typically occur much more rapidly (similar to an
intravenous bolus) than with oral administration. Absorption
through the nasopharyngeal mucosa also avoids a first pass
through the liver and for some drugs this will increase
the proportion of drug reaching the systemic circulation. Timolol,
which exhibits extensive first pass metabolism is such a case.
The drops can act as a systemic “bolus” – an infusion of the drug
Into the bloodstream. Only 1-7% of the eye drop enters the eye
Through the cornea. This is sufficient to have the desired effect of
lowering intraocular pressure. Approximately 80% of the drug
reaching the tear (lacrimal)duct is absorbed systemically, meaning
that it enters the bloodstream. This is responsible for many of the
side effects associated with glaucoma treatment medications
administered through eye drops.
It is for these reasons Mr Raj would advise closure of the eye lids
for a few minutes after application of drops and also to put gentle
pressure on the skin over the inner corner of your eye.
For private patients & referrals
Mr Akash Raj
Consultant Ophthalmologist, Glaucoma specialist & Cataract surgeon
Stourside Hospital (part of West midland Hospital)
60 Bradley Road
Stourbridge
DY8 1UX
01384 505 183
(Alternate:
Monday Evenings)
Appointments:
01384 912966
Private Secretary: Tara Ralph : 01384 632 636
Mr Akash Raj
Consultant Ophthalmologist, Glaucoma & Cataract specialist.
For NHS Referrals through GP/Opticians
Mr Akash Raj
Consultant Ophthalmologist (Glaucoma Lead)
Pensnett Road
Dudley
West Midlands
DY1 2HQ
Phone: 01384456111
Extn. 5815 (NHS Secretary: Lyn Eaton)